300+ investors in your industry, stage, and region Get
Any industry
Hospitality
Video Games
EdTech
Restaurants
Google
Construction
Photography
Cryptocurrency
Clean Energy
CleanTech
Big Data
Email
Artificial Intelligence
Social Impact
Energy
Mobile
Consumer
Health Care
Enterprise Software
Local
Platforms
Travel
InsurTech
SaaS
Oil and Gas
Retail
Payments
Film
Marketplace
Organic Food
Fitness
Machine Learning
Agriculture (AgTech)
Gaming
Social Network
B2B
Wellness
Education
Medical Device
Automotive
eSports
Sports
Legal
Biotechnology
Renewable Energy
Facebook
Blockchain
Software
Medical
Web3
Theatre
Recruiting
Crowdfunding
Infrastructure
Venture Capital
Beauty
Fashion
Social
Celebrity
LGBT
Wine and Spirits
Climate
Cannabis
Art
Music
Real Estate
Sporting Goods
Mobile Apps
FinTech
Finance
Digital Media
Manufacturing
Social Media
Financial Services
Franchise
Life Science
Non Profit
Internet
Mobile Advertising
Android
Sustainability
Proptech
Hardware
Impact
Food and Beverage
Transportation
Biotech
Enterprise
Publishing
Community
Media (Entertainment)
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
Japan
South Korea
Singapore
Burkina Faso
LATAM
Brazil
Africa
Gibraltar
Egypt
Oceania
Taiwan
Zimbabwe
Tunisia
Sweden
Hong Kong
Nigeria
Togo
Croatia
Iran
Guinea
Kyrgyzstan
Haiti
Norway
Lesotho
Isle of Man
Liberia
Malawi
Nepal
Mexico
Madagascar
Russian Federation
Sudan
Pakistan
Tajikistan
Zambia
Romania
Oman
Puerto Rico
Poland
Colombia
Guernsey
Cameroon
China
Armenia
Costa Rica
Czech Republic
Kuwait
Marshall Islands
Luxembourg
Malta
Namibia
Mozambique
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Australia
Jamaica
Sri Lanka
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Uganda
Myanmar
Turkey
Uruguay
Moldova
Morocco
Seychelles
Botswana
Paraguay
France
South Africa
Denmark
Georgia
Ghana
Iraq
Portugal
Philippines
Sierra Leone
El Salvador
Senegal
India
Germany
Canada
Ireland
Saudi Arabia
Latvia
Kenya
Mali
Malaysia
Rwanda
Tanzania
United States
Indonesia
Middle East
Bermuda
Dominican Republic
Asia
Albania
Angola
Europe
Cyprus
Spain
Qatar
Argentina
Bangladesh
Barbados
Belgium
Austria
Ethiopia
Jordan
Azerbaijan
Ecuador
Bulgaria
Faroe Islands
Estonia
Bahrain
Bahamas
Jersey
Bolivia
Belize
Algeria
Belarus
Finland
Italy
Hungary
Israel
Grenada
Honduras
Iceland
Lithuania
Cambodia
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors
Download Find emails Save list
Open database

Top 50 Life Science VC Funds & Investors in United Kingdom (October 2026)

The most active venture capital funds investing in United Kingdom Life Science startups. This investor list is updated monthly from the Shizune investor database, ranked by number of investments in United Kingdom Life Science startup companies. Find investors to raise a Seed, Series A or Venture - Series Unknown round with Shizune.
Investor Relevant Deals Geography Stage Focus Round Size
SOSV
VC Fund
37 United States, China, Canada Seed, Convertible Note, Pre-Seed Biotechnology, Health Care, Software $50k–$5M
Parkwalk Advisors
VC Fund
24 United Kingdom, United States, Philippines Seed, Series A, Series B Biotechnology, Health Care, Software $991k–$44M
Oxford Science Enterprises
VC Fund
17 United Kingdom, United States, Finland Seed, Series A, Series B Health Care, Biotechnology, Medical $1.3M–$168M
UK Innovation & Science Seed Fund
VC Fund
17 United Kingdom, United States Seed, Venture - Series Unknown Biotechnology, Health Care, Medical $582k–$5.9M
Future Planet Capital
VC Fund
13 United Kingdom, United States, Singapore Seed, Convertible Note Biotechnology, Health Care, Software $670k–$5.1M
SOSV SF & NY (Fka IndieBio)
VC Fund
12 United States, United Kingdom, Canada Seed, Pre-Seed, Convertible Note Biotechnology, Health Care, Medical $50k–$5M
Syncona Partners LLP
VC Fund
12 United Kingdom, United States, Switzerland Series A, Series B, Seed Biotechnology, Medical, Health Care $1.9M–$156M
24 Haymarket
VC Fund
11 United Kingdom, United States Venture - Series Unknown, Seed, Series A Health Care, Software, Biotechnology $107k–$16M
Development Bank of Wales
VC Fund
11 United Kingdom, Australia, United States Seed, Debt Financing, Venture - Series Unknown Software, Health Care, Manufacturing $19k–$5.5M
IQ Capital
VC Fund
11 United Kingdom, United States, Germany Seed, Series A, Venture - Series Unknown Software, Artificial Intelligence, Machine Learning $1.3M–$40M
Techstart Ventures
VC Fund
9 United Kingdom, United States, Ireland Seed, Pre-Seed, Venture - Series Unknown Software, Information Technology, Artificial Intelligence $197k–$5.7M
Selvedge Venture
VC Fund
9 United Kingdom, United States, Canada Seed, Series A, Pre-Seed Biotechnology, Health Care, Medical $1.1M–$30M
Sofinnova Partners
VC Fund
9 France, United States, United Kingdom Series A, Series B, Series C Biotechnology, Health Care, Medical $7M–$105M
Maven Capital Partners
VC Fund
8 United Kingdom, United States, Germany Venture - Series Unknown, Seed, Private Equity Software, Information Technology, Manufacturing $648k–$8.3M
O2h Ventures
VC Fund
8 United Kingdom, Hungary Seed, Venture - Series Unknown, Series A Biotechnology, Health Care, Pharmaceutical $603k–$25M
GM&C Life Sciences Fund
VC Fund
8 United Kingdom, Italy, Germany Seed, Venture - Series Unknown, Series A Health Care, Biotechnology, Medical $94k–$5.8M
Scottish Enterprise
VC Fund
8 United Kingdom, United States, Switzerland Grant, Seed, Venture - Series Unknown Biotechnology, Software, Health Care $119k–$8.4M
Newable Private Investing
VC Fund
8 United Kingdom, United States Seed, Series A Software, Health Care, Biotechnology $196k–$5.6M
Angels in MedCity
VC Fund
8 United Kingdom, United States Seed, Venture - Series Unknown, Angel Health Care, Biotechnology, Medical $313k–$2.1M
Calculus Capital
VC Fund
7 United Kingdom, United States, Ireland Venture - Series Unknown, Series A Biotechnology, Software, Medical $1.9M–$10M
Archangels
VC Fund
7 United Kingdom, United States Venture - Series Unknown, Seed Software, Health Care, Biotechnology $867k–$6.6M
Seedcamp
VC Fund
6 United Kingdom, United States, France Seed, Pre-Seed, Series A Software, Artificial Intelligence, Information Technology $587k–$30M
IP Group
VC Fund
6 United Kingdom, United States, Australia Seed, Series A, Series B Biotechnology, Health Care, Information Technology $265k–$68M
Kindred Capital
VC Fund
6 United Kingdom, United States, Germany Seed, Series A, Series B Software, Artificial Intelligence, Information Technology $1.4M–$73M
Scottish Investment Bank
VC Fund
6 United Kingdom, United States, France Venture - Series Unknown, Seed, Series A Software, Biotechnology, Health Care $199k–$7.5M
SR One
VC Fund
6 United States, United Kingdom, Canada Series A, Series B, Series C Biotechnology, Health Care, Therapeutics $6M–$175M
Northern Gritstone
VC Fund
5 United Kingdom, Singapore Seed, Series A, Pre-Seed Software, Artificial Intelligence, Electronics $2.5M–$27M
Deepbridge Capital
VC Fund
5 United Kingdom, Spain, Australia Seed, Venture - Series Unknown, Series A Health Care, Biotechnology, Medical $142k–$15M
Lima Ventures
VC Fund
5 Turkey, Estonia, United Kingdom Seed, Pre-Seed Artificial Intelligence, Software, FinTech $20k–$697k
Northstar Ventures
VC Fund
5 United Kingdom, United States, Indonesia Seed, Venture - Series Unknown, Series A Software, Health Care, Information Technology $46k–$10M
Mercia Fund Managers
VC Fund
5 United Kingdom, United States, Hungary Seed, Venture - Series Unknown, Series A Software, Health Care, Biotechnology $250k–$14M
APEX Ventures
VC Fund
5 Germany, United Kingdom, Austria Seed, Series A, Pre-Seed Artificial Intelligence, Software, Health Care $552k–$28M
Amadeus Capital Partners
VC Fund
5 United Kingdom, United States, Spain Seed, Series A, Series B Software, Artificial Intelligence, Information Technology $800k–$60M
Epidarex Capital
VC Fund
5 United Kingdom, United States, Germany Series A, Series B, Seed Biotechnology, Health Care, Therapeutics $551k–$48M
Antler
VC Fund
5 United States, Singapore, Australia Pre-Seed, Seed, Series A Software, Artificial Intelligence, Information Technology $100k–$29M
Verve Ventures
VC Fund
5 Switzerland, Germany, France Seed, Series A, Series B Software, Health Care, Biotechnology $1.2M–$45M
Formic Ventures
VC Fund
5 United States, United Kingdom, Hong Kong Seed, Series A, Venture - Series Unknown Biotechnology, Health Care, Pharmaceutical $958k–$61M
Cambridge Innovation Capital
VC Fund
5 United Kingdom, United States, Ireland Series A, Series B, Seed Biotechnology, Health Care, Medical $2M–$73M
Wren Capital
VC Fund
4 United Kingdom Seed, Series A, Venture - Series Unknown Biotechnology, Health Care, Medical $1.1M–$33M
Google Ventures
VC Fund
4 United States, United Kingdom, Israel Series A, Series B, Seed Software, Health Care, Biotechnology $1.1M–$121M
Brandon Capital
VC Fund
4 Australia, United Kingdom, United States Series A, Seed, Series B Biotechnology, Health Care, Medical $673k–$81M
Catapult Ventures
VC Fund
4 United Kingdom, United States, Israel Seed, Venture - Series Unknown Health Care, Biotechnology, Medical $150k–$5.6M
Martlet Capital
VC Fund
4 United Kingdom, United States Seed, Series A, Pre-Seed Health Care, Biotechnology, Software $193k–$9.5M
Dementia Discovery Fund
VC Fund
4 United States, United Kingdom, Israel Seed, Series A, Venture - Series Unknown Biotechnology, Health Care, Therapeutics $1.6M–$78M
Acequia Capital (AceCap)
VC Fund
4 United States, United Kingdom, France Seed, Series A, Pre-Seed Software, Artificial Intelligence, Information Technology $500k–$25M
Ahren Innovation Capital
VC Fund
4 United Kingdom, United States, Israel Series A, Seed, Series B Biotechnology, Artificial Intelligence, Machine Learning $2.7M–$150M
Advent Life Sciences
VC Fund
4 United States, United Kingdom, France Series A, Series B Biotechnology, Health Care, Medical $5.5M–$105M
11.2 Capital
VC Fund
4 United States, Canada, United Kingdom Seed, Series A, Series B Software, Information Technology, Biotechnology $1M–$53M
SFC Capital
VC Fund
4 United Kingdom, United States, Canada Pre-Seed, Seed Artificial Intelligence, Software, Information Technology $131k–$2.2M
Fifty Years
VC Fund
4 United States, Germany, Canada Seed, Series A, Series B Biotechnology, Health Care, Artificial Intelligence $2M–$91M
Access all 710 VC funds in United Kingdom Life Science startups.

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Investor list

SOSV
VC Fund · Princeton, New Jersey, United States · 37 investments in United Kingdom Life Science startups

SOSV offers pre-seed capital and follow-on financial support to startups focusing on deep technology and scientific innovation. Founders utilize purpose-built laboratory facilities and engineering spaces to accelerate product development and testing. The firm facilitates connections between entrepreneurs and a network of investors through structured matchmaking events and technology summits.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Software
  • Stage:Seed, Convertible Note, Pre-Seed
  • Geography: United States, China, Canada

Investor stats

  • Total investments: 3729
  • Round size: Seed $150k–$5M; Pre-Seed $50k–$1.6M; Convertible Note $50k–$3.6M
  • Lead/follow: 37% lead, 63% follow
  • Last fund: Likely still investing — raised $306M in 2023

Portfolio highlights

  • Halla — Halla Intelligence is a digital solution that leverages over 100 billion shopper and product data points to recommend and promote what grocery items.
  • Simply Good Jars — Simply Good Jars is a B-Corp company that delivers healthy meals in reusable + returnable packaging through use of smart refrigerated kiosks placed in offices, transit centers, universities and health-systems. Driven by purpose to change that way people think about consumption, SGJ introduces sustainable business practices into their everydayoperations with a zero-waste goal. For every jar returned back to the company for reuse, they will help feed someone in need and ensure that no packaging materials end up in landfills.
  • Verdex Technologies — Verdex Technologies is an advanced materials platform technology that uses nanofibers to disrupt industries. Verdex doesn't just compete, it innovates and disrupts.
Show all investments...

Parkwalk Advisors
VC Fund · London, England, United Kingdom · 24 investments in United Kingdom Life Science startups, 8 in the past 12 months

Parkwalk is a London-based fund management firm. Parkwalk invests in UK technology companies that have IP backing and freedom to operate, generally spun out of UK universities. Their funds seek to generate capital gains for their investors, enhanced by the attractive tax relief provided by EIS. Parkwalk entered this investment sector in 2009, anticipating a wave of tax-efficient incentives launched by the UK Government to stimulate innovative emerging technology companies and thereby help drive economic growth. Parkwalk utilises academic, technology transfer, venture capital and personal networks developed over many years to gain access to the highest calibre deal-flow. In 2017 Parkwalk joined forces with IP Group plc, a leading intellectual property commercialisation company that is listed on the Main Market of the London Stock Exchange under the ticker symbol IPO. As at March 2019 the combined group has net assets of £1.2bn.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Software
  • Stage:Seed, Series A, Series B
  • Geography: United Kingdom, United States, Philippines

Investor stats

  • Total investments: 338
  • Round size: Seed $991k–$4.9M; Series A $1.6M–$14M; Series B $1.8M–$44M
  • Lead/follow: 27% lead, 73% follow
  • Last fund: Likely actively investing — fund raised in 2024

Portfolio highlights

  • K3 Metrology — K3 Metrology is a specialist metrology company commercialising laser‑based 3D coordinate measurement technology developed at the National Physical Laboratory. The company’s platform is designed to provide high‑accuracy, uncertainty‑aware dimensional data in large‑volume industrial environments, supporting inspection and assembly processes inadvanced manufacturing. Its systems integrate into production workflows where traceable measurements are required across complex geometries and large structures. The technology is applied in sectors such as aerospace, defence, and nuclear, where dimensional integrity and process control are critical.
  • MoA Technology — We harness the principles of natural selection to accelerate discovery for better, safer herbicides so farmers can continue to feed the world.
  • Quantum Motion — Quantum Motion delivers scalable silicon-based quantum computing using standard semiconductor manufacturing technology.
Show all investments...

Oxford Science Enterprises
VC Fund · Oxford, Oxfordshire, United Kingdom · 17 investments in United Kingdom Life Science startups

Oxford Science Enterprises is the university-partnered venture firm. We work with the University of Oxford to build companies that create fundamental technologies: science-based businesses capable of tackling the planet’s toughest problems. We invest in life science, AI and software, healthcare, and deep tech to create companies taking on challenges like nuclear fusion, quantum computing and developing treatments and cures for infectious diseases. Founded in 2015, we’ve raised over £600M to create a world-class technology ecosystem, and combine our deep experience with a network of investors, entrepreneurs and sector-experts to find co-investment, build businesses, and hire senior management talent.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Seed, Series A, Series B
  • Geography: United Kingdom, United States, Finland

Investor stats

  • Total investments: 210
  • Round size: Seed $1.3M–$12M; Series A $6.3M–$45M; Series B $9.1M–$168M
  • Lead/follow: 39% lead, 61% follow
  • Last fund: Likely still investing — raised $299M in 2022

Portfolio highlights

  • Salience Labs — Salience Labs is building a hybrid photonic-electronic chip for AI. We have designed a massively parallel, ultra-high-throughput Photonic Tensor Processing Unit. Photonics allows data to be modulated at up to 100 GHZ, and allows for high levels of parallelization using multiplexing. We integrate this photonic unit into a SoC architecture designedto exploit its high throughput for AI inference. Salience Labs technology is based on decades of research collaboration between Oxford University and the University of Münster, Germany.
  • OMass Therapeutics — OMass Therapeutics is a drug discovery company exploiting novel mass spectrometry platforms to develop therapeutics against challenging disease targets.
  • Beacon Therapeutics — Beacon aids in restoring and improving the vision of patients with ophthalmic gene therapy. Find out more.
Show all investments...

UK Innovation & Science Seed Fund
VC Fund · Harwell, Oxfordshire, United Kingdom · 17 investments in United Kingdom Life Science startups

UKI2S, formally the Rainbow Seed Fund, is an investment fund backed by the government, providing seed funding to science & technology start-ups and SMEs

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Seed, Venture - Series Unknown
  • Geography: United Kingdom, United States

Investor stats

  • Total investments: 151
  • Round size: Seed $582k–$5.9M; Venture - Series Unknown $1M–$4.8M
  • Lead/follow: 32% lead, 68% follow
  • Last fund: May invest from a new fund soon — last raise in 2014

Portfolio highlights

  • Zentraxa — NATURE ENGINEERED FOR PURPOSE Through millions of years of evolution, nature has found solutions to the most difficult problems. Inspired by the diversity of nature, we precision engineer bespoke biomaterials to meet the toughest challenges across
  • StandardX — StandardX is a deep-tech company building the isotope refinery powered by a scalable, compact particle accelerator platform.
  • SILVIA BIO — SilVia Bio develops technologies to analyze and optimize mammalian cell factories used in biomanufacturing. The company focuses on identifying critical parameters that limit bioproduction yield and product quality in cell systems such as CHO and HEK cells. Its platform provides cell profiling services that generate interpretable data on manufacturing-relevant bottlenecks. Based on these insights, SilVia Bio designs and supplies precision media additives formulated to address specific rate-limiting cellular processes. The offerings are intended for biopharmaceutical and biomanufacturing teams seeking to improve titre, cell performance, and consistency in production processes. SilVia Bio also collaborates with industrial partners to apply its platform within real manufacturing environments.
Show all investments...

Future Planet Capital
VC Fund · London, England, United Kingdom · 13 investments in United Kingdom Life Science startups

Brilliant Ideas. Brilliant People. Brilliant Minds.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Software
  • Stage:Seed, Convertible Note
  • Geography: United Kingdom, United States, Singapore

Investor stats

  • Total investments: 288
  • Round size: Seed $670k–$5.1M
  • Lead/follow: 5% lead, 95% follow
  • Last fund: Likely still investing — raised $23M in 2022

Portfolio highlights

  • Unloq AI — Unloq is a Decision Intelligence Platform that turns your company data and live market signals into governed strategic recommendations. Approved, tracked, measured.
  • Nourished — At Nourished we create innovative. personalised nutrition stacks that are truly unique to you. Vegan, waste-free and always made to order.
  • K3 Metrology — K3 Metrology is a specialist metrology company commercialising laser‑based 3D coordinate measurement technology developed at the National Physical Laboratory. The company’s platform is designed to provide high‑accuracy, uncertainty‑aware dimensional data in large‑volume industrial environments, supporting inspection and assembly processes inadvanced manufacturing. Its systems integrate into production workflows where traceable measurements are required across complex geometries and large structures. The technology is applied in sectors such as aerospace, defence, and nuclear, where dimensional integrity and process control are critical.
Show all investments...

SOSV SF & NY (Fka IndieBio)
VC Fund · San Francisco, California, United States · 12 investments in United Kingdom Life Science startups

IndieBio, re-named SOSV SF and SOSV NY in 2026, are two of SOSV’s three deeply resourced facilities for deep tech founders. The third is SOSV's HAX, in Newark, NJ. SOSV is the most active deep tech venture capital firm globally.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Seed, Pre-Seed, Convertible Note
  • Geography: United States, United Kingdom, Canada

Investor stats

  • Total investments: 676
  • Round size: Seed $250k–$5M; Pre-Seed $50k–$525k; Convertible Note $150k–$950k
  • Lead/follow: 3% lead, 97% follow

Portfolio highlights

  • FluoSphera — Fluosphera better predicts the effects of molecules through animal-free microphysiological systems, helping you to discover more efficient drugs with less adverse side effects.
  • Giraffe Bio — Giraffe Bio uses AI and biomolecules to optimize metal extraction, increase yield, and reduce environmental impact. Revolutionizing sustainable mining technology.
  • Transition Metal Solutions — Transition harnesses wild microbial communities to recover copper and other critical metals from low-grade mining resources.
Show all investments...

Syncona Partners LLP
VC Fund · London, England, United Kingdom · 12 investments in United Kingdom Life Science startups

Syncona is a FTSE250 company focused on founding, building and funding healthcare companies to deliver transformational treatments to patients in areas of high unmet need.

Show more...

Investment focus

  • Industry: Biotechnology, Medical, Health Care
  • Stage:Series A, Series B, Seed
  • Geography: United Kingdom, United States, Switzerland

Investor stats

  • Total investments: 78
  • Round size: Seed $1.9M–$17M; Series A $13M–$87M; Series B $29M–$156M
  • Lead/follow: 56% lead, 44% follow

Portfolio highlights

  • OMass Therapeutics — OMass Therapeutics is a drug discovery company exploiting novel mass spectrometry platforms to develop therapeutics against challenging disease targets.
  • Beacon Therapeutics — Beacon aids in restoring and improving the vision of patients with ophthalmic gene therapy. Find out more.
  • Re-Aim Therapeutics — Re‑Aim Therapeutics is a UK‑based biotech start‑up developing functional cures for T cell–mediated autoimmune diseases by selectively depleting pathogenic T‑cell subsets. Its lead asset, REA‑001, is a monoclonal antibody designed to potently and precisely eliminate disease‑causing type‑17 T cells, aiming to reset the immune system and achievedurable, treatment‑free remission in multiple autoimmune conditions.
Show all investments...

24 Haymarket
VC Fund · London, England, United Kingdom · 11 investments in United Kingdom Life Science startups

24Haymarket is an investment network which included several highly-experienced private equity and venture capital investors, seasoned entrepreneurs, and senior operators. Investing up to £5 million in growth companies in the UK and Europe. They invested their own capital in direct alignment with entrepreneurs and actively support their growth agenda and join the board of the companies in which they invest. Since inception in 2011, 24Haymarket has invested in more than 50 high-growth businesses.

Show more...

Investment focus

  • Industry: Health Care, Software, Biotechnology
  • Stage:Venture - Series Unknown, Seed, Series A
  • Geography: United Kingdom, United States

Investor stats

  • Total investments: 108
  • Round size: Seed $736k–$3.7M; Series A $1.8M–$16M; Venture - Series Unknown $107k–$4.3M
  • Lead/follow: 41% lead, 59% follow

Portfolio highlights

  • WATR — WATR is the integrated system for real-time water or soil quality monitoring. Our products are robust, reliable, accurate, easy to use and benchmarked for accuracy.
  • pixlbio (formerly DefiniGEN) — Generate metabolic disease phenotypes in primary-like human cells using the best-in-class human iPSC differentiation platform. Find out more here!
  • Previsico — Live, property-level surface water and flash flood forecasting. Previsico gives insurers, brokers and large organisations 48-hour advance flood warnings - specific enough to act on, proven to mitigate losses.
Show all investments...

Development Bank of Wales
VC Fund · Cardiff, Cardiff, United Kingdom · 11 investments in United Kingdom Life Science startups

Development Bank of Wales is an independent company, providing commercial funding to Welsh SMEs. They invests private and public funds, including EU funds.

Show more...

Investment focus

  • Industry: Software, Health Care, Manufacturing
  • Stage:Seed, Debt Financing, Venture - Series Unknown
  • Geography: United Kingdom, Australia, United States

Investor stats

  • Total investments: 296
  • Round size: Seed $279k–$3M; Debt Financing $19k–$3.7M; Venture - Series Unknown $383k–$5.5M
  • Lead/follow: 61% lead, 39% follow
  • Last fund: May invest from a new fund soon — raised $27M in 2018

Portfolio highlights

  • Reacta Biotech — Reacta Biotech has been established to develop, manufacture and commercialise oral food challenge materials to pharmaceutical standards of Good Manufacturing Practice (GMP).
  • MeOmics Technology — MeOmics Technology is a biotech company with a focus on improving the diagnosis and treatment of mental health illnesses. The company operates in the manufacturing industry and has a team of 9 employees. The team includes experts in Neuronal Cell Biology and Neuropsychopharmacology. The company's mission is to leverage technology to enhancethe understanding and treatment of mental health conditions.
  • Outlook Expeditions — Outlook Expeditions provide overseas educational expeditions, adventure travel and service-learning projects for schools.
Show all investments...

IQ Capital
VC Fund · Cambridge, Cambridgeshire, United Kingdom · 11 investments in United Kingdom Life Science startups

IQ Capital is a dedicated European deep tech venture capital firm, built on the conviction that frontier technology will underpin the next generation of globally significant companies. We back founders leveraging scientific breakthroughs to build enduring global businesses. We have invested in over 100 of Europe's most ambitious deep tech teams across six funds since 2005.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Machine Learning
  • Stage:Seed, Series A, Venture - Series Unknown
  • Geography: United Kingdom, United States, Germany

Investor stats

  • Total investments: 215
  • Round size: Seed $1.3M–$13M; Series A $4.7M–$40M; Venture - Series Unknown $1.4M–$30M
  • Lead/follow: 34% lead, 66% follow
  • Last fund: Likely still investing — raised $200M in 2023

Portfolio highlights

  • Mindgard — Mindgard is the leading provider of AI Red Teaming solutions.
  • Imperagen — Imperagen is a biotechnology research company focused on enzyme engineering, artificial intelligence, and synthetic biology.
  • Undecimal Bio — Undecimal Bio operates as a platform biotechnology company that develops targeted delivery mechanisms for small interfering RNA (siRNA) therapeutics. The company utilizes a proprietary platform that combines combinatorial chemistry libraries with transformer-based artificial intelligence to discover molecular conjugates capable of guiding genetic medicines to specified cells outside of the liver. This approach aims to circumvent traditional delivery constraints to expand the reach of RNA therapeutics into a broader range of therapeutic areas and human organs.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Techstart Ventures
VC Fund · Belfast, Belfast, United Kingdom · 9 investments in United Kingdom Life Science startups, 6 in the past 12 months

Techstart Ventures is a first-cheque investor for extraordinary founders pursuing uncapped global opportunities.

Show more...

Investment focus

  • Industry: Software, Information Technology, Artificial Intelligence
  • Stage:Seed, Pre-Seed, Venture - Series Unknown
  • Geography: United Kingdom, United States, Ireland

Investor stats

  • Total investments: 210
  • Round size: Seed $233k–$4M; Pre-Seed $197k–$1.3M; Venture - Series Unknown $477k–$5.7M
  • Lead/follow: 51% lead, 49% follow

Portfolio highlights

  • Go Swag — Branded swag people want to keep, designed, sourced, stored and delivered by one team to 180+ countries. Managed programmes, Studio projects and Select.
  • Saltroad — Get matched with an experienced HCPC Speech and Language Therapist based on your child's needs, your budget and your schedule. Loved by parents & children.
  • Farmdrive — Farmdrive helps supply chain partners create transparent, effective, and resilient operations from farm to shelf by streamlining data collection and simplifying farm management.
Show all investments...

Selvedge Venture
VC Fund · London, England, United Kingdom · 9 investments in United Kingdom Life Science startups

Selvedge Venture operates as a venture capital firm investing for impact in age-related medical conditions.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Seed, Series A, Pre-Seed
  • Geography: United Kingdom, United States, Canada

Investor stats

  • Total investments: 20
  • Round size: Seed $1.4M–$9.6M; Pre-Seed $1.1M–$2.5M; Series A $3.5M–$30M
  • Lead/follow: 35% lead, 65% follow

Portfolio highlights

  • Mesh Bio — We enable digital transformation of care delivery through clinical workflow automation and predictive analytics, built on gold standard clinical guidelines and best practices.
  • BIOS — BIOS Health is unlocking the potential of the nervous system in treating chronic disease by using AI-powered neural interfaces that can automatically read and write neural signals.
  • MultiOmic Health — AI-Enabled Precision Medicine for Metabolic Syndrome
Show all investments...

Sofinnova Partners
VC Fund · Paris, Ile-de-France, France · 9 investments in United Kingdom Life Science startups

Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Series B, Series C
  • Geography: France, United States, United Kingdom

Investor stats

  • Total investments: 353
  • Round size: Series A $7M–$70M; Series B $10M–$105M; Series C $12M–$100M
  • Lead/follow: 47% lead, 53% follow
  • Last fund: Likely actively investing — fresh fund, raised $755M in 2025

Portfolio highlights

  • Odoo — From ERP to CRM, eCommerce and CMS. Download Odoo or use it in the cloud. Grow Your Business.
  • HighLife — HighLife is driven by a mission to deliver innovative treatment options to patients suffering from heart valve diseases.
  • EnginZyme — Enzymatic chemistry for cleaner ingredients in personal care, food and pharma. Enginzyme's patented EziG platform makes enzymes work at industrial scale.
Show all investments...

Maven Capital Partners
VC Fund · Glasgow, Glasgow City, United Kingdom · 8 investments in United Kingdom Life Science startups

Maven is one of the UK's leading private equity and investment firms. We provide essential capital and expertise to help businesses unlock their potential.

Show more...

Investment focus

  • Industry: Software, Information Technology, Manufacturing
  • Stage:Venture - Series Unknown, Seed, Private Equity
  • Geography: United Kingdom, United States, Germany

Investor stats

  • Total investments: 231
  • Round size: Seed $783k–$5M; Private Equity $981k–$6.4M; Venture - Series Unknown $648k–$8.3M
  • Lead/follow: 74% lead, 26% follow
  • Last fund: May invest from a new fund soon — raised $132M in 2019

Portfolio highlights

  • KubeNet — We are KubeNet - a multi-award winning technology solutions provider based in Glasgow. Whether it's Managed IT, IT Support, Cloud, Connectivity, Voice or Cyber Security, we're by your side as your trusted technology partner.
  • Tixserve — Secure, Trackable, Interactive Digital Tickets for Live Events
  • ReadyGo Diagnostics — ReadyGo Diagnostics has invented a novel “Diagnostic Pen”. Low cost, intuitive to use from the raw sample, the ReadyGo Pen will be a game-changer in the newly emerging consumer diagnostics market, offering a yes/no answer in minutes, based on molecular analysis.
Show all investments...

O2h Ventures
VC Fund · 8 investments in United Kingdom Life Science startups

Transforming UK biotech breakthroughs into impact. o2h Ventures offers SEIS/EIS and growth-stage funds to back visionary teams from seed to clinical success.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Pharmaceutical
  • Stage:Seed, Venture - Series Unknown, Series A
  • Geography: United Kingdom, Hungary

Investor stats

  • Total investments: 60
  • Round size: Seed $603k–$7.3M; Series A $1.9M–$25M; Venture - Series Unknown $1.1M–$2.9M
  • Lead/follow: 47% lead, 53% follow
  • Last fund: May invest from a new fund soon — last raise in 2019

Portfolio highlights

  • Healx — Healx is a mission-driven technology company pioneering the next wave of drug discovery in order to bring novel, effective treatments to rare disease patients around the world. There are 7,000 known rare diseases that affect 400 million people across the globe, but only 5% of those conditions have an approved treatment. By combining frontier AItechnology with deep drug discovery and development expertise, Healx can accelerate the pace, increase the scale and improve the chance of success of rare disease treatment development in order to meet this huge unmet need and have unprecedented patient impact. Founded in Cambridge, UK, in 2014 by Dr Tim Guilliams (a Biochemical Engineer and tech entrepreneur) and Dr David Brown (co-inventor of Viagra and former Global Head of Drug Discovery at Roche), Healx has raised $70 million to date. For more information, visit www.healx.io.
  • Atelerix — Discover Atelerix's hypothermic hydrogels for reliable cell preservation and ambient temperature shipping. Ensure fresh, viable cell samples.
  • Monument Therapeutics — Monument Therapeutics is a biotechnology company intended to develop drugs to treat serious diseases of the central nervous system.
Show all investments...

GM&C Life Sciences Fund
VC Fund · Alderley Edge, Cheshire, United Kingdom · 8 investments in United Kingdom Life Science startups

The GM&C Life Sciences Fund is a seed and early stage venture capital fund targeting life sciences businesses located in the Greater Manchester and Cheshire & Warrington region. The Fund is managed by Catapult Venture Managers ("Catapult Ventures").The Fund is based at Alderley Park, which is well recognised as a site ofnational importance, being the largest life sciences campus of its kind in the UK with more than 500,000 sq. ft. of top-end laboratory and related space and facilities. Until recently, the Park was the R&D headquarters for AstraZeneca.Since 2002, Catapult Ventures has backed a significant number of companies across a broad range of life sciences, including therapeutics (such as Abzena and Oxford BioTherapeutics), medical devices (such as Monica Healthcare and Probe Scientific), contract research organisations (such as R5 Pharmaceuticals and FDAS), diagnostics developers (such as Lumora and Biofortuna), as well as developers of technology used in healthcare applications (such as Oxford Cryosystems and Accutronics). The Fund is the result of a collaboration between Cheshire and Warrington Enterprise Partnership, Greater Manchester Combined Authority, Cheshire East Council, and Manchester Science Partnerships.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Seed, Venture - Series Unknown, Series A
  • Geography: United Kingdom, Italy, Germany

Investor stats

  • Total investments: 36
  • Round size: Seed $94k–$1.9M; Series A $1.9M–$4.2M; Venture - Series Unknown $4.3M–$5.8M
  • Lead/follow: 64% lead, 36% follow

Portfolio highlights

  • ScubaTx — ScubaTx is a breakthrough organ preservation device organ transplant. The ScubaTx device will leverage world-leading expertise in software design to commercialise a proven but unexploited organ preservation technique, Persufflation. ScubaTx will offer healthcare providers significant net savings, an
  • Infex Therapeutics — Infex Therapeutics acquire, develop and license drugs to treat pandemic infections.
  • Monument Therapeutics — Monument Therapeutics is a biotechnology company intended to develop drugs to treat serious diseases of the central nervous system.
Show all investments...

Scottish Enterprise
VC Fund · Glasgow, Glasgow City, United Kingdom · 8 investments in United Kingdom Life Science startups, 35 in the past 12 months

Scotland's business advice, support and funding agency. Explore our products and services to find the right support for your business and apply online today.

Show more...

Investment focus

  • Industry: Biotechnology, Software, Health Care
  • Stage:Grant, Seed, Venture - Series Unknown
  • Geography: United Kingdom, United States, Switzerland

Investor stats

  • Total investments: 402
  • Round size: Seed $387k–$4.3M; Grant $119k–$4.8M; Venture - Series Unknown $681k–$8.4M
  • Lead/follow: 37% lead, 63% follow

Portfolio highlights

  • CSignum — Revolutionising underwater communications with electromagnetic technology for seamless data integration between surface & submerged devices.
  • GLORIAH — Nurse founded, natural intimate hydration oils and gels for menopause.
  • SolarSub — SolarSub is an environmental firm that offers floating solar cooling system.
Show all investments...

Newable Private Investing
VC Fund · London, England, United Kingdom · 8 investments in United Kingdom Life Science startups

Newable exists to power business growth. Our strategy of Buy, Grow, Realise focuses on the regulated B2B market.

Show more...

Investment focus

  • Industry: Software, Health Care, Biotechnology
  • Stage:Seed, Series A
  • Geography: United Kingdom, United States

Investor stats

  • Total investments: 106
  • Round size: Seed $196k–$3.1M; Series A $1.5M–$5.6M
  • Lead/follow: 25% lead, 75% follow
  • Last fund: May invest from a new fund soon — last raise in 2019

Portfolio highlights

  • Delta g — Delta g Limited is a quantum technology and gravity gradiometry company. A spin-out from the University of Birmingham our technology has applications in industries as varied as civil engineering, infrastructure, defence, rail, navigation and resource exploration. Experts from science, engineering an
  • Weldfast — Weldfast is a manufacturer and supplier of welding consumables, abrasives, chemicals, premium gas equipment, and safety products.
  • EarSwitch — Empowering new ways to control and connect with the world through in-ear biometric switch and sensor technology
Show all investments...

Angels in MedCity
VC Fund · London, England, United Kingdom · 8 investments in United Kingdom Life Science startups

Angels in MedCity is a partnership between MedCity, London Business Angels and Angels4LifeSciences. The programme aims to introduce new people to investing and investing in the healthcare/life sciences sector via investor workshops and introduce business angels to investment opportunities from highly-selected and trained companies.With aparticular focus on drug therapies, digital health and medical device technologies, Angels in MedCity brings potential investors together with life sciences experts in a programme aimed at both people who are new to investing and experienced investors who have little or no experience in the life sciences sector. The aim is to build investor understanding in the life sciences sector and support life sciences companies to gain funding to commercialise their ideas.Angels in MedCity has created a community of investors supported through a programme of investor workshops. Using case studies and tips from experienced investors in the field, the workshops explain how to identify and structure a good deal in the life sciences sector, as well as provide expert advice on tax breaks and legal issues.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Seed, Venture - Series Unknown, Angel
  • Geography: United Kingdom, United States

Investor stats

  • Total investments: 20
  • Round size: Seed $482k–$2M; Angel $313k–$1.2M; Venture - Series Unknown $1.1M–$2.1M
  • Lead/follow: 10% lead, 90% follow

Portfolio highlights

  • Calira — Calira (formerly Clustermarket). Give researchers an easy way to book equipment, improve equipment utilisation, and get structured lab usage data.
  • Atelerix — Discover Atelerix's hypothermic hydrogels for reliable cell preservation and ambient temperature shipping. Ensure fresh, viable cell samples.
  • Clustermarket — The intuitive lab management system for all academic research facilities and industrial laboratories that need to efficiently manage equipment bookings.
Show all investments...

Calculus Capital
VC Fund · London, England, United Kingdom · 7 investments in United Kingdom Life Science startups

At Calculus Capital they are specialists in creating and managing tax efficient private equity funds for the individual. Funds that are ideal for today's market - offering generous tax benefits, and significant growth potential within a sensible risk profile. They look to make £2-5 million investments in established companies with proven management teams and a successful product or service. Their entrepreneurial flair, combined with their experience and sound commercial judgement has resulted in a diversified investment portfolio and an impressive track record. In June 2013 Calculus Capital was top ranked in the prestigious Martin Churchill Tax Efficient Review for the 6th year in a row. The Government has recently shown its support for EIS funds, by maintaining the five generous tax benefits and widening the scope of EIS investments. These changes benefit Calculus Capital's rigorous and proven strategy. As a result they are experiencing their strongest pipeline of prospective investments yet.

Show more...

Investment focus

  • Industry: Biotechnology, Software, Medical
  • Stage:Venture - Series Unknown, Series A
  • Geography: United Kingdom, United States, Ireland

Investor stats

  • Total investments: 81
  • Round size: Series A $2.5M–$10M; Venture - Series Unknown $1.9M–$8.3M
  • Lead/follow: 65% lead, 35% follow
  • Last fund: Likely still investing — fund raised in 2024

Portfolio highlights

  • Edify Systems — The Human-First AI platform for multi-site food and beverage operators. Tighter margins, less waste, more time on the floor.
  • Grateful — Grateful provides cashless tipping and trunk management software that integrates QR/NFC, EPOS systems, and compliance reporting.
  • Resurrect Bio — Resurrect Bio is a disease resistance trait discovery company. Using AI and our high-throughput in planta screening platform we provide traits for breeders.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Archangels
VC Fund · Edinburgh, Edinburgh, City of, United Kingdom · 7 investments in United Kingdom Life Science startups, 8 in the past 12 months

Established in 1992. Archangels is the oldest continuously operating business angel syndicate in the World. Investing in IP-rich tech & life sciences companies in Scotland, UK.

Show more...

Investment focus

  • Industry: Software, Health Care, Biotechnology
  • Stage:Venture - Series Unknown, Seed
  • Geography: United Kingdom, United States

Investor stats

  • Total investments: 88
  • Round size: Seed $1.3M–$6.6M; Venture - Series Unknown $867k–$6.3M
  • Lead/follow: 53% lead, 47% follow

Portfolio highlights

  • CSignum — Revolutionising underwater communications with electromagnetic technology for seamless data integration between surface & submerged devices.
  • Corvidae — Corvidae is a software company that provides data analysts, digital marketing, e commerce, and paid media solutions.
  • iGii — Integrated Graphene enable better products with a revolutionary design for manufacture process producing the world's highest quality pure 3D Graphene Foam, Gii.
Show all investments...

Seedcamp
VC Fund · London, England, United Kingdom · 6 investments in United Kingdom Life Science startups, 40 in the past 12 months

By Your Side from Day One

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Information Technology
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United Kingdom, United States, France

Investor stats

  • Total investments: 624
  • Round size: Seed $658k–$8M; Pre-Seed $587k–$3.5M; Series A $5M–$30M
  • Lead/follow: 18% lead, 82% follow
  • Last fund: Likely actively investing — fresh fund, raised $220M in 2026

Portfolio highlights

  • Rayon — Built for Speed. Designed for Teams.
  • Metaview — Metaview uplevels the most outcome-defining part of your recruitment process: your interviews.
  • Solvera AI — Solvera is an AI-native engineering firm on a mission to unleash the potential of every building engineer with AI. It develops advanced proprietary AI systems to help design better buildings, significantly faster, establishing a brand-new standard for MEP engineering.
Show all investments...

IP Group
VC Fund · London, England, United Kingdom · 6 investments in United Kingdom Life Science startups

IP Group's core business is the creation of value for its shareholders and partners through the commercialisation of intellectual property originating from research intensive institutions. Their strength lies in managing this process from finding suitable intellectual property to commercialise to either helping develop businesses and create value out of them, or identifying and establishing appropriate commercial partnerships to do so. IP Group's extensive expertise in this area combined with its inside knowledge of both industry and finance have enabled the group to create a formidable track record of consistently delivering excellent results for their companies, for their partners and for their shareholders.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Information Technology
  • Stage:Seed, Series A, Series B
  • Geography: United Kingdom, United States, Australia

Investor stats

  • Total investments: 234
  • Round size: Seed $265k–$7.6M; Series A $2.4M–$30M; Series B $7.9M–$68M
  • Lead/follow: 22% lead, 78% follow
  • Last fund: Likely actively investing — fresh fund, raised $50M in 2026

Portfolio highlights

  • Eight19 — Eight19, located in Cambridge, UK, develops and manufactures plastic photovoltaics for energy harvesting, for the internet of things and for off-grid applications. Through the innovative use of industry-standard, high-volume, roll-to-roll processes and solution-based organic photoactive materials, the company has a highly cost-effective route forscaling-up its technology to supply the largest markets. Eight19 is currently producing modules on a small scale for commercial partners with applications in indoor energy harvesting for wireless sensor and controllers, signage and display, and outdoor power for portable electronics. Our plastic PV modules benefit from flexibility, thinness, light-weight and robustness.
  • Matter Machine — Matter Machine is an AI-driven materials discovery company that creates technologies that use materials chemistry, machine learning, and automated experimentation to speed up the discovery and optimization of next-generation materials.
  • Mach42 — Machine Discovery is a University of Oxford spin-out commercializing new machine learning technology. We leverage proprietary neural network technology to accelerate expensive calculations — and we do it with minimal data and 99.9% fidelity.
Show all investments...

Kindred Capital
VC Fund · London, England, United Kingdom · 6 investments in United Kingdom Life Science startups, 11 in the past 12 months

A new model for Venture Capital where every founder we back becomes a co-owner of the fund.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Information Technology
  • Stage:Seed, Series A, Series B
  • Geography: United Kingdom, United States, Germany

Investor stats

  • Total investments: 131
  • Round size: Seed $1.4M–$16M; Series A $7.9M–$33M; Series B $8M–$73M
  • Lead/follow: 29% lead, 71% follow
  • Last fund: Likely actively investing — fresh fund, raised $8M in 2026

Portfolio highlights

  • RobCo — Easily automate the repetitive tasks in your production facility with modular industrial robots from RobCo.
  • Bios Life — Bios Life is a technology-enabled healthcare company built to empower individuals to proactively manage their cancer risk, redefining personalized cancer screening and survivorship.
  • Scarlet — Scarlet certifies software medical devices. We’re Europe's only Notified Body specialised in software and AI, and have crafted a certification process that is built for software, and is thus significantly more efficient.This is how we deliver on our mission to hasten the world’s transition to accessible healthcare: by enabling manufacturersto release their medical software and AI to those who need it without unnecessary delays.We are designated as a UK Approved Body by the MHRA, and an EU Notified Body by the Dutch Ministry of Health and the European Commission.
Show all investments...

Scottish Investment Bank
VC Fund · Glasgow, Glasgow City, United Kingdom · 6 investments in United Kingdom Life Science startups

Speak with our team, who can help you find sources of finance, engage with funders and secure investment to grow your business.

Show more...

Investment focus

  • Industry: Software, Biotechnology, Health Care
  • Stage:Venture - Series Unknown, Seed, Series A
  • Geography: United Kingdom, United States, France

Investor stats

  • Total investments: 290
  • Round size: Seed $331k–$3.1M; Series A $1.7M–$7.5M; Venture - Series Unknown $199k–$4.1M
  • Lead/follow: 13% lead, 87% follow
  • Last fund: May invest from a new fund soon — last raise in 2015

Portfolio highlights

  • Corvidae — Corvidae is a software company that provides data analysts, digital marketing, e commerce, and paid media solutions.
  • IOTech — Discover IOTech Systems. Deploy, manage, and scale AI-driven, data-rich industrial systems at the edge with our open edge data platform.
  • RoslinCT — We are the prefered global partner for cell and gene therapy solutions. With our wealth of expertise and infrastructure, we can support you at every step of your advanced therapy journey.
Show all investments...

SR One
VC Fund · Cambridge, Massachusetts, United States · 6 investments in United Kingdom Life Science startups

SR One Capital Management is a leading trans-Atlantic biotech venture capital firm that partners with top entrepreneurs, scientists and investment partners to seek to build elite biotechnology companies. Our mission is to translate ground-breaking technologies into next generation medicines to benef

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series A, Series B, Series C
  • Geography: United States, United Kingdom, Canada

Investor stats

  • Total investments: 203
  • Round size: Series A $6M–$100M; Series B $15M–$114M; Series C $22M–$175M
  • Lead/follow: 33% lead, 67% follow
  • Last fund: Likely actively investing — fresh fund, raised $237M in 2025

Portfolio highlights

  • CalciMedica — CalciMedica is a clinical-stage biopharmaceutical company advancing CRAC channel inhibitors for pulmonary hypertension and acute pancreatitis.
  • Windward Bio — Windward Bio is a clinical-stage, drug development company committed to improving outcomes for people living with serious immunological diseases.
  • Korsana Biosciences — Korsana Biosciences develops THETA-enabled antibody therapies for neurodegenerative diseases. The company focuses on shuttled monoclonal antibodies that cross the blood-brain barrier to reach central nervous system targets. Its lead program, KRSA-028, is an investigational anti-amyloid beta antibody for Alzheimer’s disease that uses a transferrinreceptor-based shuttle and Fc engineering to improve brain delivery and dosing. Korsana is also advancing additional THETA-based programs for undisclosed neurodegenerative indications.
Show all investments...

Northern Gritstone
VC Fund · Leeds, Leeds, United Kingdom · 5 investments in United Kingdom Life Science startups

Northern Gritstone is an investment firm focused on investing in advanced materials, energy, health technology and cognitive computation.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Electronics
  • Stage:Seed, Series A, Pre-Seed
  • Geography: United Kingdom, Singapore

Investor stats

  • Total investments: 43
  • Round size: Seed $2.5M–$7M; Pre-Seed $2.7M–$6.2M; Series A $3M–$27M
  • Lead/follow: 65% lead, 35% follow
  • Last fund: Likely actively investing — fund raised in 2025

Portfolio highlights

  • Imperagen — Imperagen is a biotechnology research company focused on enzyme engineering, artificial intelligence, and synthetic biology.
  • Matter Machine — Matter Machine is an AI-driven materials discovery company that creates technologies that use materials chemistry, machine learning, and automated experimentation to speed up the discovery and optimization of next-generation materials.
  • SILVIA BIO — SilVia Bio develops technologies to analyze and optimize mammalian cell factories used in biomanufacturing. The company focuses on identifying critical parameters that limit bioproduction yield and product quality in cell systems such as CHO and HEK cells. Its platform provides cell profiling services that generate interpretable data on manufacturing-relevant bottlenecks. Based on these insights, SilVia Bio designs and supplies precision media additives formulated to address specific rate-limiting cellular processes. The offerings are intended for biopharmaceutical and biomanufacturing teams seeking to improve titre, cell performance, and consistency in production processes. SilVia Bio also collaborates with industrial partners to apply its platform within real manufacturing environments.
Show all investments...

Deepbridge Capital
VC Fund · Chester, Cheshire, United Kingdom · 5 investments in United Kingdom Life Science startups

Deepbridge is a different kind of investment manager. They work closely with financial advisers and investors to design innovative products, ranging from investment in technology growth companies to asset-backed renewable energy projects. They also partner with innovative and committed management teams to help UK based companies realise theirpotential and become successful leading-edge businesses.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Seed, Venture - Series Unknown, Series A
  • Geography: United Kingdom, Spain, Australia

Investor stats

  • Total investments: 91
  • Round size: Seed $142k–$2.4M; Series A $2M–$15M; Venture - Series Unknown $259k–$2.8M
  • Lead/follow: 69% lead, 31% follow
  • Last fund: Likely still investing — raised $1.4M in 2022

Portfolio highlights

  • upLYFT — upLYFT creates next-generation wearable technology that continuously analyses biomechanics and movement biomarkers, giving athletes, clinicians and physiotherapists precise insight into performance, recovery and injury risk.
  • GeneralPractice.AI — GeneralPractice.AI - Infusing Artificial Intelligence into the Fabric of General Practice
  • Spotlight Pathology — Spotlight Pathology develops decision support tools powered by artificial intelligence (AI) to help in the diagnosis of blood cancers.
Show all investments...

Lima Ventures
VC Fund · Istanbul, Istanbul, Turkey · 5 investments in United Kingdom Life Science startups

Collaboration with outstanding initiators with exceptional insights, from inception through all levels of progress. Lima Ventures supports visionary founders as well as provides certain services to early startups. We seek innovative technology-driven entrepreneurs who generate and lead companies that will inspire millions.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Software, FinTech
  • Stage:Seed, Pre-Seed
  • Geography: Turkey, Estonia, United Kingdom

Investor stats

  • Total investments: 39
  • Round size: Seed $20k–$697k; Pre-Seed $50k–$100k
  • Lead/follow: 15% lead, 85% follow

Portfolio highlights

  • Shippn — International package forwarding service. Shop from Amazon, Shein, Macy's worldwide. Fast shipping with DHL & FedEx. Trusted by 50,000+ customers.
  • heybooster — heybooster is the creator of a platform for marketing analysis that aids e-commerce managers in finding chances for revenue growth and in making better choices. It provides clients with digital reporting, online meetings, online communication, an online project management system, and an online playbook that helps them discover problems, findpossibilities for revenue growth, and cut expenses.
  • Mars Studios — Mars Studios is an experienced team of growth hackers & marketers that can help you to increase your revenue. Rocket Your App to Success: Mars Studios
Show all investments...

Northstar Ventures
VC Fund · Newcastle Upon Tyne, Newcastle upon Tyne, United Kingdom · 5 investments in United Kingdom Life Science startups, 9 in the past 12 months

Northstar Ventures invests venture capital in early and later stage, high growth companies tackling global challenges, focusing on climate tech and healthy ageing.

Show more...

Investment focus

  • Industry: Software, Health Care, Information Technology
  • Stage:Seed, Venture - Series Unknown, Series A
  • Geography: United Kingdom, United States, Indonesia

Investor stats

  • Total investments: 278
  • Round size: Seed $46k–$1.4M; Series A $295k–$10M; Venture - Series Unknown $261k–$3.8M
  • Lead/follow: 25% lead, 75% follow
  • Last fund: Likely still investing — raised $20M in 2024

Portfolio highlights

  • OneClickComply — OneClickComply automates ISO 27001, SOC 2, Cyber Essentials and 240+ standards: evidence from 13,000+ tools, one-click fixes and an in-house audit team.
  • Land Digital — Land Digital is a tech, web design, web creation, content marketing, digital marketing, SEO, and mobile application agency.
  • Magnitude Biosciences — Magnitude Biosciences is a biotechnology firm combine experience in ageing research, the nematode C. elegans and automation.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Mercia Fund Managers
VC Fund · Henley In Arden, Warwickshire, United Kingdom · 5 investments in United Kingdom Life Science startups

Mercia Asset Management provides equity and debt to UK businesses with growth ambition. We are your investment partners from scale-up to exit.

Show more...

Investment focus

  • Industry: Software, Health Care, Biotechnology
  • Stage:Seed, Venture - Series Unknown, Series A
  • Geography: United Kingdom, United States, Hungary

Investor stats

  • Total investments: 148
  • Round size: Seed $250k–$2.1M; Series A $1.3M–$14M; Venture - Series Unknown $394k–$5.3M
  • Lead/follow: 68% lead, 32% follow
  • Last fund: May invest from a new fund soon — last raise in 2013

Portfolio highlights

  • Ben — Ben is the all-in-one platform for any company to personalise benefits and reward.Our secret? Marrying a modern software (SaaS) platform with per-employee Mastercards and financial infrastructure. That’s how Ben instantly adds employee choice to your existing benefits, unlocks access to hundreds of additional options through Ben Card, all whilesaving you time and money.
  • Distil.ai — Distil.ai is a software platform that helps businesses to understand their customers’ behavior and identify buying signals.
  • MRC Engineering — MRC Engineering Providing a different option to the UK Rail Industry for Telecoms Design. Nationally renowned design specialists who provide extraordinary ...
Show all investments...

APEX Ventures
VC Fund · Vienna, Wien, Austria · 5 investments in United Kingdom Life Science startups

APEX Ventures is a deep-tech and medical focused venture capital firm, run by founders with complimentary backgrounds driven by the same mission.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Software, Health Care
  • Stage:Seed, Series A, Pre-Seed
  • Geography: Germany, United Kingdom, Austria

Investor stats

  • Total investments: 62
  • Round size: Seed $1.4M–$8M; Pre-Seed $552k–$9.1M; Series A $5.7M–$28M
  • Lead/follow: 29% lead, 71% follow
  • Last fund: May invest from a new fund soon — last raise in 2020

Portfolio highlights

  • Quibim — Quibim builds AI tools that turn MRI, CT and PET data into actionable predictions for hospitals and biopharma. Trusted in 470+ centers worldwide.
  • iPremom — iPremom is a healthcare technology company that develops molecular diagnostic solutions for the early detection and prediction of pregnancy complications, particularly preeclampsia.
  • Jago Coffee — Jago Coffee serves freshly brewed coffee beverages wherever you are through a fleet of fully electric mobile cafes.
Show all investments...

Amadeus Capital Partners
VC Fund · Cambridge, Cambridgeshire, United Kingdom · 5 investments in United Kingdom Life Science startups, 8 in the past 12 months

Amadeus Capital Partners, Venture Capital For Technology Companies. We Back Entreprenuers To Win. Contact Our Experienced Team Of Investors Today

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Information Technology
  • Stage:Seed, Series A, Series B
  • Geography: United Kingdom, United States, Spain

Investor stats

  • Total investments: 278
  • Round size: Seed $800k–$9.2M; Series A $2.6M–$30M; Series B $7.2M–$60M
  • Lead/follow: 32% lead, 68% follow
  • Last fund: Likely still investing — raised $85M in 2023

Portfolio highlights

  • iPremom — iPremom is a healthcare technology company that develops molecular diagnostic solutions for the early detection and prediction of pregnancy complications, particularly preeclampsia.
  • Respiro Diagnostics — Respiro is harnessing insights from the breath to detect lung cancer earlier, non-invasively, and without scans or radiation. Built for use in everyday care settings.
  • iPronics — iPronics develops the innovative concepts of general-purpose integrated programmable photonic systems.
Show all investments...

Epidarex Capital
VC Fund · Bethesda, Maryland, United States · 5 investments in United Kingdom Life Science startups

Epidarex Capital invests in early-stage, high growth life science and health technology companies in under-ventured markets. Its international team is led by Sinclair Dunlop, Kyp Sirinakis and Liz Roper. With offices in the United States and United Kingdom Epidarex Capital’s investors represent a cross-section of leading universities, international corporations, development agencies and financial institutions. Epidarex was created to meet the need for more sector-specific financial backing for young companies, including spin-outs from leading research universities.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series A, Series B, Seed
  • Geography: United Kingdom, United States, Germany

Investor stats

  • Total investments: 53
  • Round size: Seed $551k–$8.5M; Series A $2.6M–$40M; Series B $2.4M–$48M
  • Lead/follow: 45% lead, 55% follow
  • Last fund: Likely actively investing — fresh fund, raised $145M in 2026

Portfolio highlights

  • Mironid — Google Analytics is a web analysis service provided by Google. Google utilizes the data collected to track and examine the use of www.mironid.com, to prepare reports on its activities and share them with other Google services. Google may use the data collected to contextualize and personalize the ads of its own advertising network.
  • RougeTx — RougeTx is a Netherlands-based biotech developing first-in-class small-molecule therapies for vascular diseases caused by pericyte dysfunction. Its lead candidate, RTX-001, targets hereditary haemorrhagic telangiectasia (HHT), an inherited disorder involving fragile blood vessels and recurrent bleeding.
  • Epsilogen — IGEM Therapeutics is a developer of an immuno-oncology company intended to develop immunoglobulin antibodies to treat cancer.The company's offerings include IgE-based drugs targeting solid tumors, enabling patients to kill parasites which reside in human tissue, also the home of the solid tumor.
Show all investments...

Antler
VC Fund · Singapore, Central Region, Singapore · 5 investments in United Kingdom Life Science startups

Build your next company with Antler, a global day zero investor enabling exceptional founders to start great companies, from the very beginning. Apply now!

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Information Technology
  • Stage:Pre-Seed, Seed, Series A
  • Geography: United States, Singapore, Australia

Investor stats

  • Total investments: 2387
  • Round size: Seed $158k–$4.6M; Pre-Seed $100k–$600k; Series A $4.1M–$29M
  • Lead/follow: 43% lead, 57% follow
  • Last fund: Likely actively investing — fresh fund, raised $7.5M in 2026

Portfolio highlights

  • iiba — Iiba is a geospatial platform that specializes in providing location information related to child-rearing.
  • Obud — Obud is a wellness reservation systems that is designed for holistic health and lifestyle management purposes. The company's systems offer a comprehensive suite of tools for booking wellness activities, managing schedules, and accessing curated wellness programs, enabling wellness centers to streamline their operations, enhance userengagement, and promote a balanced and healthy lifestyle.
  • Plouton AI —
Show all investments...

Verve Ventures
VC Fund · Zug, Zug, Switzerland · 5 investments in United Kingdom Life Science startups, 9 in the past 12 months

Verve Ventures has invested in more than 140 science and technology startups. We support visionary and resilient entrepreneurs from day one and are a reliable partner for the entire journey. We typically invest EUR 1-3m in early as well as later stage rounds of European high tech startups.

Show more...

Investment focus

  • Industry: Software, Health Care, Biotechnology
  • Stage:Seed, Series A, Series B
  • Geography: Switzerland, Germany, France

Investor stats

  • Total investments: 305
  • Round size: Seed $1.2M–$12M; Series A $2.1M–$18M; Series B $3.9M–$45M
  • Lead/follow: 14% lead, 86% follow
  • Last fund: Likely still investing — raised $61M in 2022

Portfolio highlights

  • Piomic — Non-invasive treatment with minimal staff supervision to produce a durable structural, functional and cosmetic closure of hard-to-heal wounds.
  • Aylight — Aylight develops semiconductor laser and photonics platforms designed to improve optical connectivity in AI datacenters and related infrastructure. The company focuses on frequency modulated comb laser technology that generates multiple stable wavelengths from a single InP-based laser cavity. Its architecture produces an equidistant, RF-lockedwavelength grid that aligns with dense wavelength-division multiplexing requirements and reduces control complexity and power consumption. Aylight targets use cases in AI datacenter interconnects, quantum computing hardware, precision metrology, and communication equipment. Its products aim to integrate with terabit optical links and wavelength-division multiplexing systems while remaining compatible with existing fabrication processes.
  • Undecimal Bio — Undecimal Bio operates as a platform biotechnology company that develops targeted delivery mechanisms for small interfering RNA (siRNA) therapeutics. The company utilizes a proprietary platform that combines combinatorial chemistry libraries with transformer-based artificial intelligence to discover molecular conjugates capable of guiding genetic medicines to specified cells outside of the liver. This approach aims to circumvent traditional delivery constraints to expand the reach of RNA therapeutics into a broader range of therapeutic areas and human organs.
Show all investments...

Formic Ventures
VC Fund · San Francisco, California, United States · 5 investments in United Kingdom Life Science startups

Formic Ventures is a diversified venture capital firm that makes early-stage investments in biotechnology startups focused on human longevity as well as technology startups and companies that make human lives more meaningful.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Pharmaceutical
  • Stage:Seed, Series A, Venture - Series Unknown
  • Geography: United States, United Kingdom, Hong Kong

Investor stats

  • Total investments: 48
  • Round size: Seed $958k–$9M; Series A $17M–$61M; Venture - Series Unknown $2.4M–$3.1M
  • Lead/follow: 2% lead, 98% follow

Portfolio highlights

  • SonoThera — Explore therapeutic ultrasound for non-invasive, targeted genetic medicine delivery that improves precision and biodistribution. Learn more.
  • cheMastery — Echo handles repetitive tasks with accuracy and precision, allowing your chemists to tackle high-value challenges.
  • Biogenesis — Clinical research platform tailored towards industry sponsors, clinical research sites & patients
Show all investments...

Cambridge Innovation Capital
VC Fund · Cambridge, Cambridgeshire, United Kingdom · 5 investments in United Kingdom Life Science startups, 6 in the past 12 months

As a team, we have a passion for science and its potential to drive change. Through our expertise and our position in one of the country's most powerful science and technology ecosystems, we're able to identify and support the most promising entrepreneurs in knowledge intensive businesses and help them achieve their vision.With our financial backing and expert guidance, we're excited to enable the pioneers in life sciences and deep tech to create world-leading companies whose unique ideas bring financial success and global impact.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Series B, Seed
  • Geography: United Kingdom, United States, Ireland

Investor stats

  • Total investments: 119
  • Round size: Seed $2M–$31M; Series A $2.6M–$73M; Series B $8.2M–$68M
  • Lead/follow: 37% lead, 63% follow
  • Last fund: Likely actively investing — fresh fund, raised $332M in 2025

Portfolio highlights

  • Trent AI — The agentic AI security platform that works like an AI security engineer, finding the real risk in your code, cloud, and AI agents and verifying every fix.
  • Salience Labs — Salience Labs is building a hybrid photonic-electronic chip for AI. We have designed a massively parallel, ultra-high-throughput Photonic Tensor Processing Unit. Photonics allows data to be modulated at up to 100 GHZ, and allows for high levels of parallelization using multiplexing. We integrate this photonic unit into a SoC architecture designedto exploit its high throughput for AI inference. Salience Labs technology is based on decades of research collaboration between Oxford University and the University of Münster, Germany.
  • TRIMTECH Therapeutics — Transformative treatments for CNS and inflammatory disorders by selectively destroying disease-causing protein aggregates
Show all investments...

Wren Capital
VC Fund · London, England, United Kingdom · 4 investments in United Kingdom Life Science startups

Wren is an angel investor in science, engineering and software. They founded Wren in 2011 and have invested in 50 companies so far.Wren is well known in the early stage investment community and has co-invested with a wide range of both angel and institutional investors. From software and semiconductors to genome editing, and from medical devices to satellites, they are interested in sectors where technical ingenuity and hard work can produce long term value. They look for people with a deep understanding of their markets. The founders they invest in are smart and they get things done. Wren typically invests £50,000 to £200,000 per funding round. Difficult problems take time to solve, so they are patient with their investments. Their aim is to get deals done and they take a pragmatic approach to doing so.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Seed, Series A, Venture - Series Unknown
  • Geography: United Kingdom

Investor stats

  • Total investments: 35
  • Round size: Seed $1.9M–$5M; Series A $2.5M–$33M; Venture - Series Unknown $1.1M–$8.9M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • SenseAI — SenseAIsoftware dramatically speeds up image acquisition while reducing sample damage from high-energy electron beams, offering up to 100x improvements in efficiency without loss of image integrity.
  • SILVIA BIO — SilVia Bio develops technologies to analyze and optimize mammalian cell factories used in biomanufacturing. The company focuses on identifying critical parameters that limit bioproduction yield and product quality in cell systems such as CHO and HEK cells. Its platform provides cell profiling services that generate interpretable data on manufacturing-relevant bottlenecks. Based on these insights, SilVia Bio designs and supplies precision media additives formulated to address specific rate-limiting cellular processes. The offerings are intended for biopharmaceutical and biomanufacturing teams seeking to improve titre, cell performance, and consistency in production processes. SilVia Bio also collaborates with industrial partners to apply its platform within real manufacturing environments.
  • Singular Photonics — Singular Photonics is a startup that creates SPAD-based image sensors.
Show all investments...

Google Ventures
VC Fund · Mountain View, California, United States · 4 investments in United Kingdom Life Science startups

GV supports innovative founders moving the world forward.

Show more...

Investment focus

  • Industry: Software, Health Care, Biotechnology
  • Stage:Series A, Series B, Seed
  • Geography: United States, United Kingdom, Israel

Investor stats

  • Total investments: 1517
  • Round size: Seed $1.1M–$15M; Series A $6M–$100M; Series B $15M–$121M
  • Lead/follow: 30% lead, 70% follow
  • Last fund: May invest from a new fund soon — raised $100M in 2014

Portfolio highlights

  • SolveAI —
  • Smarterer — Individuals and Fortune 500 companies use Smarterer to help close the gap between the skills they have and the skills they need. Their dynamic assessment engine leverages the freshest crowdsourced tests around, to rapidly pinpoint skill level with a credible score. In November 2014, Pluralsight, the global leader in online learning for serioussoftware developers, IT specialists and creative technologists, acquired Smarterer. As the world's largest curated e-learning library for professionals, the company offers instant access to more than 3,500 courses authored by top experts. Smarterer will continue to power crowdsourced assessments for freelancer marketplaces, e-learning providers and enterprise companies anywhere people need to prove their skills to connect with professional opportunities. The Smarterer community has answered over 56 million during 1.7 million test sessions, across hundreds of tests.
  • EveryONE Medicines — EveryONE Medicines develops nucleic acid therapeutics for pathogenic genetic mutation of patients.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Brandon Capital
VC Fund · Melbourne, Victoria, Australia · 4 investments in United Kingdom Life Science startups

Brandon Capital invests in the most promising biomedical opportunities that have the potential to improve the lives of patients.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Seed, Series B
  • Geography: Australia, United Kingdom, United States

Investor stats

  • Total investments: 83
  • Round size: Seed $673k–$9.7M; Series A $5.2M–$81M; Series B $6.4M–$68M
  • Lead/follow: 34% lead, 66% follow
  • Last fund: Likely actively investing — fresh fund, raised $290M in 2025

Portfolio highlights

  • Ena Respiratory — Ena Respiratory is a biotechnology company seeking to transform the treatment and prevention of respiratory infections and the effectiveness of vaccines.Ena Respiratory novel, synthetic Toll-like receptor 2 (TLR2) receptor agonists have been shown to activate the innate immune system in the respiratory tract and prevent viral and bacterialdissemination to the lungs.
  • Lumonus — Hello, we are Lumonus! We empower oncology care teams through software solutions and services.
  • OncoRes Medical — OncoRes Medical develops an imaging technology to provide intraoperative information available to surgeons to assist with the identification of tumor and healthy tissue.OncoRes Medical is an early-stage medical device company located in Perth, Western Australia and is developing the patent-protected technology in collaboration with leadingresearchers at the University of Western Australia and the Harry Perkins Institute of Medical Research and breast cancer surgeons at the Western Australian public health system.With funding provided by the Medical Research Commercialisation Fund (MRCF), OncoRes Medical aims to develop the technology for use in clinical applications that require the real-time assessment of tissue microstructure.
Show all investments...

Catapult Ventures
VC Fund · Leicester, Leicester, United Kingdom · 4 investments in United Kingdom Life Science startups

The team behind Catapult Ventures are among the most experienced venture capital investors in the UK.Their experience spans a range of sectors from healthcare and pharmaceuticals to luxury consumer brands, manufacturing and software, as well as all stages: from start-ups and pre-revenue IP developers to company floatation and billions of poundsin revenue. Their administration team is equally experienced with each member having more than 10 years experience in a venture capital environment.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Seed, Venture - Series Unknown
  • Geography: United Kingdom, United States, Israel

Investor stats

  • Total investments: 105
  • Round size: Seed $150k–$5.6M; Venture - Series Unknown $370k–$5M
  • Lead/follow: 25% lead, 75% follow
  • Last fund: May invest from a new fund soon — last raise in 2018

Portfolio highlights

  • Path Robotics — We create manufacturing robots that autonomously scan, position, and weld your parts without the need for skilled welders or robot programmers.
  • Pickle Robot — We make robots that unload trucks without retrofitting the warehouse
  • Anello Photonics — Anello Photonics is a technology company developing a silicon photonic optical gyroscope to navigate, position, and motion track autonomous applications in challenging GPS-jammed and spoofed environments. The company's technology portfolio spans over 28 issued patents, and over 44 pending patents, and includes an AI-based sensor fusion engine.It serves the robotics, defense, construction, agriculture, and autonomous vehicles industries.
Show all investments...

Martlet Capital
VC Fund · Cambridge, Cambridgeshire, United Kingdom · 4 investments in United Kingdom Life Science startups

Martlet Capital is an early-stage investor based in Cambridge, providing patient capital to deep technology and life science startups with high growth potential. Investing in the future.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Software
  • Stage:Seed, Series A, Pre-Seed
  • Geography: United Kingdom, United States

Investor stats

  • Total investments: 55
  • Round size: Seed $637k–$7.5M; Pre-Seed $193k–$1.2M; Series A $1M–$9.5M
  • Lead/follow: 13% lead, 87% follow

Portfolio highlights

  • Xampla — Xampla's natural plant polymer technology is the innovative technology powering materials to change the world with plastic-free replacements and more.
  • Infinitopes — Infinitopes is a cancer research organization whose mission is to strengthen the immune system so that it can stop metastases and save lives. The company's platform creates healthcare systems and therapy designs to integrate high-efficiency vector delivery systems with optimal tumor target identification technologies in early-stage clinicaltrials, allowing patients to prevent cancer and tumors from taking their lives
  • AllFocal Optics — AllFocal Optics revolutionizes display technology through groundbreaking nanophotonic solutions.
Show all investments...

Dementia Discovery Fund
VC Fund · London, England, United Kingdom · 4 investments in United Kingdom Life Science startups

SV Health Investors is a specialist healthcare fund manager, investing across multiple stages and sectors. Our goal is to transform healthcare one investment at a time.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Seed, Series A, Venture - Series Unknown
  • Geography: United States, United Kingdom, Israel

Investor stats

  • Total investments: 56
  • Round size: Seed $4.8M–$20M; Series A $7M–$78M; Venture - Series Unknown $1.6M–$48M
  • Lead/follow: 39% lead, 61% follow
  • Last fund: Likely actively investing — fresh fund, raised $269M in 2025

Portfolio highlights

  • Leal Therapeutics — Leal Therapeutics develops novel therapeutics for patients.
  • Violet Therapeutics — Violet Therapeutics is a healthcare company that operates in stealth mode.
  • TRIMTECH Therapeutics — Transformative treatments for CNS and inflammatory disorders by selectively destroying disease-causing protein aggregates
Show all investments...

Acequia Capital (AceCap)
VC Fund · Seattle, Washington, United States · 4 investments in United Kingdom Life Science startups

We are a leading early-stage investment platform. We are at the center of a global ecosystem that attracts and fuels the technical founders and product teams building the next wave of global businesses.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Information Technology
  • Stage:Seed, Series A, Pre-Seed
  • Geography: United States, United Kingdom, France

Investor stats

  • Total investments: 415
  • Round size: Seed $1M–$7.6M; Pre-Seed $500k–$3.3M; Series A $3.3M–$25M
  • Lead/follow: 5% lead, 95% follow
  • Last fund: Likely actively investing — fresh fund, raised $2.9M in 2026

Portfolio highlights

  • Rapidata — Fast and reliable data labeling that powers your AI. Define your label needs now and get the results in minutes.
  • Devplan — Devplan turns customer feedback into ranked, ready-to-build specs for your engineers and AI agents.
  • Applied Atomics, Inc. — Powering the next 1,000 years of advanced industry with co-located nuclear power plants.
Show all investments...

Ahren Innovation Capital
VC Fund · London, England, United Kingdom · 4 investments in United Kingdom Life Science startups

Ahren Innovation Capital is a World Changing Institution. A group of highly diverse, creative and original thinkers, at the cutting edge of their domains.

Show more...

Investment focus

  • Industry: Biotechnology, Artificial Intelligence, Machine Learning
  • Stage:Series A, Seed, Series B
  • Geography: United Kingdom, United States, Israel

Investor stats

  • Total investments: 46
  • Round size: Seed $2.7M–$8.5M; Series A $10M–$58M; Series B $15M–$150M
  • Lead/follow: 39% lead, 61% follow
  • Last fund: Likely still investing — fund raised in 2022

Portfolio highlights

  • Hiverge — Building algorithmic superintelligence.
  • KluraLabs — CodiKoat are a revolutionary company developing and producing the future of antiviral protection. CodiKoat's antiviral surface coating technology is ISO certified and is the fastest COVID-killing protection of its kind in the world, with limitless uses.
  • Cassidy Bio — A biotechnology company developing AI-driven genomic foundation models
Show all investments...

Advent Life Sciences
VC Fund · London, England, United Kingdom · 4 investments in United Kingdom Life Science startups

Advent Life Sciences is a venture team investing in life sciences businesses. The team consists of 11 professionals with extensive scientific, medical and operational experience, and a long-standing track record of entrepreneurial and investment success across the UK, Europe and the US. The Firm invests in a range of sectors within life sciences,principally in new drug discovery, enabling technologies, and med tech. Realizations in the last three years include Algeta, Avila, CN Creative, EUSA, Micromet. Current investments include Acutus, Biocartis, Cellnovo, f2G, NeRRe,

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Series B
  • Geography: United States, United Kingdom, France

Investor stats

  • Total investments: 70
  • Round size: Series A $5.5M–$51M; Series B $21M–$105M
  • Lead/follow: 36% lead, 64% follow
  • Last fund: May invest from a new fund soon — last raise in 2021

Portfolio highlights

  • Cyted — Cyted focuses on providing digital diagnostic infrastructure to drive the earlier detection of disease. Our technologies use AI and novel biomarkers to improve patient outcomes.
  • Glycomine — We are developing a PMM2-CDG substrate replacement therapy. GLM101 is a mannose-1 phosphate treatment.
  • Beacon Therapeutics — Beacon aids in restoring and improving the vision of patients with ophthalmic gene therapy. Find out more.
Show all investments...

11.2 Capital
VC Fund · San Francisco, California, United States · 4 investments in United Kingdom Life Science startups

In physics, 11.2 km/s is the escape velocity from Earth's gravity. They focus on emerging technologies such as AI, cybersecurity, robotics, quantum, new space, computational therapeutics, synthetic biology. ​They believe great people are leading indicators of a company's success. 11.2 Capital’s technical background, operationalexperience, and a strong network of amazing advisors and international partners particularly in Asia deliver a unique set of resources to entrepreneurs. While they are happy to help companies across the full range of early-stage company questions, areas where they concentrate include technical recruiting, partnerships (OEM and distribution partnerships for smart hardware companies, data partnerships for data-driven healthcare companies), customer introductions (CISO introductions for security companies, provider introductions for healthcare companies), and follow-on financings.

Show more...

Investment focus

  • Industry: Software, Information Technology, Biotechnology
  • Stage:Seed, Series A, Series B
  • Geography: United States, Canada, United Kingdom

Investor stats

  • Total investments: 57
  • Round size: Seed $1M–$12M; Series A $7.3M–$26M; Series B $15M–$53M
  • Lead/follow: 12% lead, 88% follow

Portfolio highlights

  • Noetik — Noetik is an AI-native biotechnology company. Our mission is to leverage advanced machine learning methods to discover and develop cancer immunotherapies.
  • Mantle — Mantle is an engineering and manufacturing company that has developed metal 3D printing technology to produce high-resolution parts that meet the critical needs of applications from automotive and aerospace to consumer product design and prototyping.
  • CryptoNumerics — HIPAA, GDPR and Data Residency requirements restrict your ability to conduct data science. CryptoNumerics removes these restrictions. CryptoNumerics enables you to create privacy protected datasets with quantifiable privacy risk. In addition, you can build statistical and machine learning models that protect people’s privacy. Our team consists ofengineers and visionaries with previous experience in C-Level roles at Fortune 500 companies, founding teams of venture backed growth stage start-ups, and accomplished R&D leaders.
Show all investments...

SFC Capital
VC Fund · London, England, United Kingdom · 4 investments in United Kingdom Life Science startups, 60 in the past 12 months

Discover the UK's leading SEIS Fund, offering tax-efficient investments in innovative startups. Join thousands of savvy investors and raise capital for your business with SFC Capital.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Software, Information Technology
  • Stage:Pre-Seed, Seed
  • Geography: United Kingdom, United States, Canada

Investor stats

  • Total investments: 578
  • Round size: Seed $131k–$2.2M; Pre-Seed $173k–$846k
  • Lead/follow: 33% lead, 67% follow
  • Last fund: May invest from a new fund soon — raised $1.9M in 2019

Portfolio highlights

  • Keylr — Services partner for property managers. Book reliable, top-rated professionals for your properties with e-props.
  • Furbnow — Furbnow - Your companion for home improvements for the future
  • Checkboard — Complete your identity verification and payments without the paperwork. Checkboard handles your ID, open banking, and payments from one app.
Show all investments...

Fifty Years
VC Fund · San Francisco, California, United States · 4 investments in United Kingdom Life Science startups

WE BACK HEROES using technology to solve the world's biggest problems

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Artificial Intelligence
  • Stage:Seed, Series A, Series B
  • Geography: United States, Germany, Canada

Investor stats

  • Total investments: 184
  • Round size: Seed $2M–$15M; Series A $8.5M–$37M; Series B $16M–$91M
  • Lead/follow: 17% lead, 83% follow
  • Last fund: Likely still investing — raised $90M in 2021

Portfolio highlights

  • Gridware — Using remote telemetry and edge AI, Gridware wildfire prevention technology powers a grid that is smarter and more reliable than ever before.
  • Onepot.ai — Search 2.7 billion make-on-demand analogs from onepot CORE, get a quote, and we synthesize and QC them in our US-based lab. AI-powered custom synthesis CRO.
  • Adaption Labs — Adaptation creates AI systems that adjust to changing real-world circumstances.
Show all investments...

Life Science VC funding in United Kingdom at a glance

Stats across 712 deals from 710 investors.

710
investors
in United Kingdom Life Science startups
712
deals
in United Kingdom Life Science startups
$3M
median round
in United Kingdom Life Science startups
43%
lead investors
lead at least one round
25%
Seed
most common funding stage

Access all 710 VC funds in United Kingdom Life Science startups.

Open List

FAQ

Is Shizune data fresh/accurate?

Shizune has monitored hundreds of funding sources since 2020.

Our investor database is updated every day, so investor data is always fresh.

All metrics are calculated from confirmed public rounds, so the data is accurate.

Can I download investor list?

To download the Life Science VC Funds in United Kingdom investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.

You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.

Can I access investor database?

To access all 710 VC funds investing in United Kingdom Life Science startups and 48,091+ more investors, create a Shizune account.

Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.

The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.

You can enrich with email and download the data.

Does Shizune have investor emails and contacts?

Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.

To guarantee the highest discovery rate, we search across 20+ contact search tools.

To maximize delivery rate and reduce bounce rate, we validate emails.

You can enrich your investor list with Shizune. Download it too.

What is Shizune?

Shizune is a 48,091 investor database updated daily.

With Shizune you can:

  • browse the database
  • use smart matching
  • enrich with emails
  • download

All you need to find investors for your startup.

Who is Shizune for?

Shizune is built for startup founders by startup founders.

If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.

Is Shizune free?

Shizune is free forever. You can search and browse investors for free.

Email search and export are paid features.

For full info, visit our pricing.

Who built Shizune?

Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.

Contact 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!

More investor lists

Broader lists